Bridgewater Associates’s Arcosa ACA Stock Holding History

Bridgewater Associates’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-22,588	Closed	-$2.4M	–	1000
2026 Q1	$2.4M	Sell	22,588 -376	-2%	-$42.8K	0.01%	614
2025 Q4	$2.44M	Buy	+22,964	New	+$2.32M	0.01%	721
2023 Q4	–	Sell	-14,718	Closed	-$1.06M	–	743
2023 Q3	$1.06M	Buy	+14,718	New	+$1.12M	0.01%	596

Other funds holding ACA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Bridgewater Associates's ACA Position: Q2 2026 in Review

Bridgewater Associates sold out of Arcosa (ACA) in Q2 2026, closing a stake of 22,588 shares — an estimated $2.4M sold.

Bridgewater Associates first reported a position in ACA in Q3 2023 and held it in 3 quarters. The position peaked at $2.44M in Q4 2025. 428 funds tracked by Wall St. Rank hold ACA as of Q2 2026.

Bridgewater Associates reported no remaining Arcosa position as of Q2 2026 after selling out during the quarter.
Bridgewater Associates sold 22,588 Arcosa shares in Q2 2026, an estimated $2.4M.
Bridgewater Associates first reported a position in Arcosa in Q3 2023 and held it in 3 quarters.
Bridgewater Associates's Arcosa position peaked at $2.44M in Q4 2025.
428 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.